Stocks › IBEX
IBEX Ltd (IBEX) stock analysis
WEAK BUY 12% confidence · analysed Aug 21, 2026
This analysis is from Aug 21, 2026 and may be out of date.
On Aug 21, 2026, our model rated IBEX Ltd (IBEX) WEAK BUY with 12% confidence at a price of $36.13. That means the signals lean positive, but they are mixed, so conviction is low.
Technical picture
The 14-day RSI is 56, showing healthy upward momentum without being stretched.
MACD is below its signal line, so short-term momentum is pointing down.
The price is above both its 50-day and 200-day moving averages, the classic picture of an uptrend.
Volume is only 0.1x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $42.99 and the swing low is $25.94; traders often treat these as resistance and support.
Price is sitting in a bullish order block, a zone where large buyers stepped in before.
Fundamentals
The company reports a profit margin of 7.5% and revenue growth of +16.8%.
In its latest quarter it earned $0.91 per share, which beat the $0.86 analysts expected, with revenue +16.8% year over year.
The next earnings report is expected around Sep 10, 2026; prices often move sharply around earnings.
Trade plan from the model
The model's long / bullish plan uses an entry near $36.48, a target of $37.50 (+2.8%) and a stop-loss at $34.09 (-6.6%).
That is a reward-to-risk ratio of about 0.4 to 1: the potential loss is bigger than the gain, a weak setup.
The plan has a time limit: reassess by Aug 31, 2026 whatever the price does.
Research notes
IBEX Ltd. bull case: the stock has recently been trading near the mid-$30s with a consensus Hold and a $40 average target**, leaving room for modest upside if execution stays solid. The latest positive catalyst was a new institutional stake disclosure from Tieton Capital Management, which added 275,035 shares and may signal continued investor interest.
Bear case: analyst coverage is still only Hold, and the stock has been roughly flat to down on the year in the latest market data, suggesting sentiment is not broadly bullish. Insider selling has also been reported over the past 90 days, which can weigh on perception even if the amounts are not large relative to market cap.
The main recent catalyst is that IBEX shares were higher on the filing/news flow around the new institutional purchase, with the stock opening around $35.77 and later showing around $36.06 in market data.
The model's one-paragraph read
Leans BUY — composite score +0.12 (WEAK BUY). Technicals: RSI 55.79, MACD bearish, price above SMA50. Fundamentals: margin 7.5%, revenue growth 16.8%. Financial results: YoY revenue +16.8%, last EPS surprise +5.8%, next earnings 2026-09-10. Smart Money Concepts: ranging / no clear structure, price retesting a bullish order block, sitting inside an unfilled bullish fair value gap. FinGPT news read: neutral. Internet research: **IBEX Ltd.** bull case: the stock has recently been trading near the mid-$30s with a **consensus Hold** and a **$40 average target**, leaving room for modest upside if execution stays solid. The latest positive catalyst was a new institutional stake disclosure from Tieton Capital Management, which added 275,035 shares and may signal continued investor interest. Bear case: analyst coverage is still only **Hold**, and the stock has been roughly **flat to down on the year** in the latest market data, suggesting sentiment is not broadly bullish. Insider selling has also been reported over the past 90 days, which can weigh on perception even if the amounts are not large relative to market cap. The main recent catalyst is that **IBEX shares were higher on the filing/news flow around the new institutional purchase**, with the stock opening around **$35.77** and later showing around **$36.06** in market data. Suggested levels: entry $36.48, target $37.5, stop-loss $34.09, exit by 2026-08-31 (10-calendar-day max hold (time-stop; reassess by this date regardless of P&L)).
Past ratings for IBEX
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Aug 21, 2026 | WEAK BUY | 12% | $36.13 | — | |
| Aug 20, 2026 | WEAK SELL | 13% | $36.19 | -0.2% | ✔ right direction |
| Aug 19, 2026 | SKIP | 4% | $36.44 | -0.9% |
"Move since" compares each call's price with the latest analysed price.
Other Technology stocks we cover
IBM · INGM · INTC · INTT · INTU · IOT · IT · JBL · KEYS · KLIC · KSPI · LITE
Frequently asked questions
Is IBEX a buy right now?
As of Aug 21, 2026, our automated model rates IBEX Ltd (IBEX) WEAK BUY with 12% confidence: the signals lean positive, but they are mixed, so conviction is low. This is a model output for education, not personal investment advice.
What is the price target for IBEX?
The model's most recent plan targets $37.50 with a stop-loss at $34.09, from an entry near $36.48.
When does IBEX Ltd report earnings next?
The next earnings report is expected around Sep 10, 2026.
What does a WEAK BUY rating mean?
A WEAK BUY rating means the signals lean positive, but they are mixed, so conviction is low.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.